Medicine guide

GOBIVAZ

As listed in the register: GOBIVAZ 100 mg, solution injectable en seringue préremplie

100 mg · solution injectable

  • Prescription only
Active substance
Golimumab
Made by
ADVANZ PHARMA LIMITED

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (SIMPONI ARIA). It describes the substance, not this exact product.

Golimumab is a human monoclonal antibody that binds to both the soluble and transmembrane bioactive forms of human TNFα.

This interaction prevents the binding of TNFα to its receptors, thereby inhibiting the biological activity of TNFα (a cytokine protein).

Half-life3 days
Mostly cleared after≈ 2 weeksfive half-lives — our arithmetic

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-09-09

Safety of the active substance

From the US prescribing label for the same active substance (SIMPONI ARIA). It describes the substance, not this exact product.

Serious warning

WARNING: SERIOUS INFECTIONS and MALIGNANCY WARNING: SERIOUS INFECTIONS and MALIGNANCY See full prescribing information for complete boxed warning.

Most common side effects

Most common adverse reactions (incidence ≥ 3%) are: upper respiratory tract infection, alanine aminotransferase increased, viral infection, aspartate aminotransferase increased, neutrophil count decreased, bronchitis, hypertension, and rash ( 6.1 ).

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

Details

Made byADVANZ PHARMA LIMITED
Active substanceGolimumab
Strength100 mg
Formsolution injectable
Routesous-cutanée
Dispensing (as stated by the register)prescription réservée aux spécialistes et services HEPATO/GASTRO-ENTEROLOGIE · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services RHUMATOLOGIE · prescription réservée aux spécialistes et services DERMATOLOGIE · médicament soumis à prescription médicale, en attente de notification de la Blue Box
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/25/1988
Name in the registerGOBIVAZ 100 mg, solution injectable en seringue préremplie
Packs1 seringue préremplie en verre de 1 mL
CIS62464897
CIP133400930328828

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.